(PROK) ProKidney - Performance 68.8% in 12m
PROK performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-75.09%
#113 in Peer-Group
Rel. Strength
89.94%
#775 in Stock-Universe
Total Return 12m
68.78%
#21 in Peer-Group
Total Return 5y
-63.11%
#73 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.73 USD |
| 52 Week Low | 0.51 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 99.49 |
| Buy/Sell Signal +-5 | 0.00 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: PROK (68.8%) vs XBI (-9.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.02% | 69.7% | 77.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.4% | -7.09% | 151% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.42% | -1.57% | 39.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.65% | 30.3% | -1.81% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.39% | -9.49% | -0.73% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
10.5% | 38.7% | -6.49% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.82% | 50.2% | -13.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.95% | 29.1% | 18.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: PROK vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PROK
| Total Return (including Dividends) | PROK | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 280.61% | 0.53% | 3.75% |
| 3 Months | 630.08% | 21.37% | 25.32% |
| 12 Months | 68.78% | -9.11% | 13.11% |
| 5 Years | -63.11% | -25.99% | 109.78% |
| Trend Score (consistency of price movement) | PROK | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -60.6% | -5.7% | 80.3% |
| 3 Months | -8.7% | 79.4% | 97.2% |
| 12 Months | -90.2% | -86.9% | 45.4% |
| 5 Years | -74.6% | -52.2% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th99.50 | 278.60% | 266.85% |
| 3 Month | %th100.00 | 501.53% | 482.58% |
| 12 Month | %th90.50 | 85.69% | 49.22% |
| 5 Years | %th67.50 | -41.13% | -75.94% |
FAQs
Does ProKidney (PROK) outperform the market?
Yes,
over the last 12 months PROK made 68.78%, while its related Sector, the SPDR S&P Biotech (XBI) made -9.11%.
Over the last 3 months PROK made 630.08%, while XBI made 21.37%.
Performance Comparison PROK vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
PROK vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 559.7% | 276.9% | 118.8% | 56% |
| US NASDAQ 100 | QQQ | 559.2% | 276.4% | 117.2% | 57% |
| German DAX 40 | DAX | 557.9% | 280.4% | 106.1% | 38% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 558.7% | 276.9% | 115.1% | 47% |
| Hongkong Hang Seng | HSI | 560.2% | 277.6% | 98.4% | 30% |
| India NIFTY 50 | INDA | 560.5% | 279.8% | 118.3% | 70% |
| Brasil Bovespa | EWZ | 560.5% | 274.7% | 96.8% | 61% |
PROK vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 561.1% | 277.1% | 114.3% | 45% |
| Consumer Discretionary | XLY | 560.5% | 278.6% | 126.6% | 53% |
| Consumer Staples | XLP | 561% | 280.2% | 118.3% | 61% |
| Energy | XLE | 556.6% | 273.8% | 122.6% | 67% |
| Financial | XLF | 561% | 277.9% | 116.3% | 41% |
| Health Care | XLV | 561.5% | 279.5% | 127.8% | 74% |
| Industrial | XLI | 559.6% | 277.5% | 111.9% | 44% |
| Materials | XLB | 558.9% | 276.9% | 115.2% | 63% |
| Real Estate | XLRE | 560.9% | 280.8% | 119.9% | 57% |
| Technology | XLK | 558.1% | 273.4% | 114.7% | 59% |
| Utilities | XLU | 561.2% | 279.3% | 116.5% | 47% |
| Aerospace & Defense | XAR | 559% | 276.8% | 100.7% | 21% |
| Biotech | XBI | 558.2% | 280.1% | 132.9% | 78% |
| Homebuilder | XHB | 561% | 274.6% | 126.7% | 65% |
| Retail | XRT | 559.7% | 279.1% | 123.5% | 59% |
PROK vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 556.1% | 274% | 125% | 73% |
| Natural Gas | UNG | 562% | 291.1% | 138% | 75% |
| Gold | GLD | 561.3% | 281.4% | 101% | 29% |
| Silver | SLV | 558.5% | 280.9% | 103.2% | 50% |
| Copper | CPER | 553.2% | 270.5% | 98.4% | 50% |
PROK vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 562.6% | 279.5% | 122.5% | 72% |
| iShares High Yield Corp. Bond | HYG | 560.4% | 279.3% | 120.4% | 59% |